About three weeks ago, COVID case rates in the United Kingdom made an abrupt about-face, spurred on by a more transmissible Omicron subvariant called BA.2. (So far, there is no reason to believe the new subvariant causes more severe disease.) Case rates are rising, too, in Switzerland and Greece…
Source: www.theatlantic.com – Read more

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market
Biopharma has finally begun catching up with the overall stock market, if the positive returns shown by the top three exchange traded funds (ETFs) since


